Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 9/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.41 |
| ▸ | POLA1 | P09884 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | POLD1 | P28340 | 1/20 | 0.39 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.39 |
| ▸ | DTYMK | P23919 | 2/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5285301 | 0.90 | POLB (0.48) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL3485976 | 0.87 | P2RY6 (0.41) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL27186873 | 0.85 | POLG (0.41) | P2RY6P2RY2P2RY4P2RX3 | |
| SCHEMBL4619794 | 0.85 | P2RY6 (0.55) | P2RY6P2RY2POLA1P2RY4 | |
| SCHEMBL18241039 | 0.83 | P2RY2 (0.44) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL28836964 | 0.81 | TK1 (0.34) | — | |
| SCHEMBL5191085 | 0.80 | POLB (0.50) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL95680 | 0.77 | P2RY6 (0.54) | P2RY6P2RY2POLA1P2RY4 | |
| SCHEMBL28794808 | 0.77 | P2RX1 (0.53) | P2RY2POLBP2RX3 | |
| SCHEMBL8440658 | 0.76 | P2RY6 (0.54) | P2RY6P2RY2POLA1P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240110237-A1 | FUNCTIONAL LIGANDS | BASE PAIR BIOTECHNOLOGIES INC (US) | 2024-04-04 | — | — | US | disclosed |
| EP-1725572-B1 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | AGCT GMBH (DE) | 2017-05-31 | — | — | EP | disclosed |
| EP-2074133-A2 | COMPONENTS AND METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | Genovoxx GmbH (DE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008043426-A2 | COMPONENTS AND METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | GENOVOXX GMBH (DE) | 2008-04-17 | — | — | WO | disclosed |
| EP-1725572-A2 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | Genovoxx GmbH (DE) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005044836-A2 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | GENOVOXX GMBH (DE) | 2005-05-19 | — | — | WO | disclosed |